Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treatment of Type 2 Diabetes

NCT05925829 is registered in ClinicalTrials.gov with Hayandra Peduli Foundation as lead sponsor.

NCT NCT05925829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05925829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treatment of Type 2 Diabetes
Lead sponsor
Hayandra Peduli Foundation
Phase
Phase 1
Overall status
Completed
Start date
January 1, 2017
Completion date
December 1, 2017
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, platelet-rich plasma, stromal vascular fraction